SEER Inquiry System - Question 20130017 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 09/07/2025 5:58 PM

Question 20130017

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

Heme & Lymph Manual & DB

Question:

Reportability--Heme & Lymphoid Neoplasms: Is reactive thrombocytosis reportable? See Discussion.

Discussion:

The doctor's impression: "Thrombocytosis, mild without other obvious hematologic difficulty. I would be most suspicious for early iron deficiency related to her prior menometrorrhagia. Would limit initial evaluation to iron studies, review of peripheral smear, and hepatic profile."

Answer:

For cases diagnosed 2010 and forward, access the Hematopoietic Database at http://seer.cancer.gov/seertools/hemelymph.

Reactive thrombocytosis is not reportable and is not an alternative name for essential thrombocythemia [9962/3].

Only the following are listed as alternate names for essential thrombocythemia in the Heme DB:

Essential hemorrhagic thrombocythemia

Essential thrombocytosis

Hemorrhagic thrombocythemia

Idiopathic hemorrhagic thrombocythemia

Idiopathic thrombocythemia

Idiopathic thrombocytosis

Primary thrombocythemia

Primary thrombocytosis

Thrombocythemia vera

SEER*Educate provides training on how to use the Heme Manual and DB. If you are unsure how to arrive at the answer in this SINQ question, refer to SEER*Educate to practice coding hematopoietic and lymphoid neoplasms. Review the step-by-step instructions provided for each case scenario to learn how to use the application and manual to arrive at the answer provided. https://educate.fhcrc.org/LandingPage.aspx.

Cancer Site Category:

Heme & Lymphoid Neoplasms

Data Item Category:

N/A

Other Category:

Reportability

Year:

2013